What is pericardial effusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Pericardial Effusion?

Pericardial effusion is an abnormal accumulation of fluid in the pericardial space that exceeds the normal physiological amount (typically 15-50 mL), which can result from inflammatory, infectious, neoplastic, metabolic, traumatic, or idiopathic causes. 1, 2

Definition and Pathophysiology

Pericardial effusion represents an increase beyond the normal volume of fluid within the pericardial cavity. 2 The fluid can manifest as different types depending on the underlying cause:

  • Transudate (hydropericardium) - typically from heart failure or metabolic causes 1, 3
  • Exudate - from inflammatory or infectious processes 1
  • Pyopericardium - purulent fluid from bacterial infection 1
  • Hemopericardium - blood accumulation from trauma, malignancy, or aortic dissection 1, 4

The hemodynamic impact depends critically on the rate of fluid accumulation rather than absolute volume. 1, 5 Rapid accumulation of even 100-200 mL over minutes to hours can cause cardiac tamponade, while slow accumulation over days to weeks allows the pericardium to stretch and accommodate large volumes (sometimes >1000 mL) before symptoms develop. 5, 6

Major Etiologies

Geographic Variation in Causes

The etiology varies dramatically by geographic region and healthcare setting:

  • Developing countries: Tuberculosis dominates, accounting for >60% of cases, especially in HIV-endemic areas 7, 8
  • Developed countries: Idiopathic causes account for up to 50% despite comprehensive evaluation, with malignancy (10-25%), infections, iatrogenic causes, and autoimmune diseases comprising other major etiologies 7, 8

Specific Causes by Category

Infectious 7:

  • Viral infections (most common in developed countries): enteroviruses, echoviruses, adenoviruses, CMV, EBV, HSV, influenza, parvovirus B19, hepatitis C, HIV
  • Tuberculosis (leading cause worldwide and in endemic regions)
  • Fungal infections (particularly in immunocompromised patients)

Neoplastic 7:

  • Secondary metastatic tumors (40 times more common than primary): lung cancer, breast cancer, lymphoma, melanoma, leukemia
  • Primary pericardial tumors (rare): mesothelioma most common
  • Critical caveat: In almost two-thirds of patients with documented malignancy, the pericardial effusion is actually caused by non-malignant diseases such as radiation pericarditis or opportunistic infections 7

Autoimmune/Inflammatory 7:

  • Systemic lupus erythematosus, Sjögren syndrome, rheumatoid arthritis, scleroderma, systemic vasculitides (account for 5-15% of cases)
  • Post-cardiac injury syndromes: post-MI pericarditis, post-pericardiotomy syndrome, post-traumatic pericarditis
  • Sarcoidosis

Metabolic/Endocrine 7:

  • Hypothyroidism (occurs in 5-30% of hypothyroid patients; effusions may be large but tamponade is rare)
  • Uremia in renal failure

Cardiovascular 7, 3:

  • Heart failure (causes transudative effusion through increased systemic venous pressure and decreased pericardial fluid reabsorption)
  • Pulmonary arterial hypertension (25-30% of cases have effusion, typically small and rarely causing hemodynamic compromise)
  • Aortic dissection with hemopericardium (occurs in 17-45% of ascending aortic dissections)

Iatrogenic/Traumatic 7:

  • Cardiac surgery, percutaneous coronary intervention, pacemaker insertion, radiofrequency ablation
  • Penetrating or non-penetrating thoracic trauma
  • Radiation therapy (causes effusion/constriction in 6-30% of patients)
  • Chemotherapy agents: anthracyclines, cyclophosphamide, cytarabine, imatinib, dasatinib, interferon-α, arsenic trioxide, docetaxel, 5-fluorouracil, osimertinib

Drug-Related 7:

  • Lupus-like syndrome: procainamide, hydralazine, methyldopa, isoniazid, phenytoin
  • Other medications: amiodarone, methysergide, mesalazine, clozapine, minoxidil, anti-TNF agents

Clinical Presentation

Symptoms

The clinical presentation varies based on the speed of accumulation and size of effusion:

Slowly developing effusions can be remarkably asymptomatic even when large, while rapidly accumulating smaller effusions present with tamponade. 1, 5

Common symptoms include 5:

  • Dyspnea on exertion progressing to orthopnea (hallmark presentation)
  • Chest pain or chest fullness
  • Nausea, dysphagia, hoarseness, hiccups (from compression of adjacent structures)
  • Non-specific symptoms: cough, weakness, fatigue, anorexia, palpitations, fever

Physical Examination

Physical examination may be completely normal in patients without hemodynamic compromise. 5 When cardiac tamponade develops, classic findings include 1, 5:

  • Neck vein distension with elevated jugular venous pressure
  • Pulsus paradoxus
  • Diminished/distant heart sounds
  • Pericardial friction rubs (rarely heard, but may be present with concomitant pericarditis)

Insidiously developing tamponade may present with complications such as renal failure, abdominal plethora, shock liver, and mesenteric ischemia. 1

Clinical Pearls for Etiology Assessment

Cardiac tamponade without inflammatory signs is associated with higher risk of neoplastic etiology (likelihood ratio 2.9). 7

Severe effusion without cardiac tamponade and without inflammatory signs is usually associated with chronic idiopathic etiology (likelihood ratio 20). 7

If inflammatory signs are present (chest pain, fever, pericardial friction rub, elevated CRP), clinical management should follow that of pericarditis. 7

In 60% of patients, the cause of pericardial effusion may be a known medical condition. 1, 7

Serosanguinous or hemorrhagic fluid can be found in malignant, post-pericardiotomy, rheumatologic, traumatic, and iatrogenic effusions, but also in idiopathic and viral forms, so fluid appearance alone cannot determine etiology. 7

Risk of Progression

Large chronic pericardial effusions are rare (2-3.5% of all large effusions). 1 However, up to one-third of patients with asymptomatic large chronic pericardial effusion develop unexpected cardiac tamponade. 1, 8, 9 Triggers for tamponade include hypovolemia, paroxysmal tachyarrhythmias, and intercurrent acute pericarditis. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pericardial Effusion in Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pericardial Effusion Presentation and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pericardial Effusion Causes and Associations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Management of pericardial effusion.

European heart journal, 2013

Research

Triage and management of pericardial effusion.

Journal of cardiovascular medicine (Hagerstown, Md.), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.